Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen

A American Diabetes. 6 glycemic targets: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S66–76.

Article  Google Scholar 

Hoffman RP, Dye AS, Huang H, Bauer JA. Glycemic variability predicts inflammation in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2016;29:1129–33.

Article  PubMed  Google Scholar 

Rodrigues R, de Medeiros LA, Cunha LM, Garrote-Filho MDS, Bernardino Neto M, Jorge PT, Resende ES, Penha-Silva N. Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment. Diabetes Res Clin Pract. 2018;144:153–60.

Article  PubMed  Google Scholar 

Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol. 2018;71:339–51.

Article  PubMed  Google Scholar 

Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr. 2018;12:181–7.

Article  PubMed  Google Scholar 

Lu M, Zuo Y, Guo J, Wen X, Kang Y. Continuous glucose monitoring system can improve the quality of glucose control and glucose variability compared with point-of-care measurement in critically ill patients: a randomized controlled trial. Medicine. 2018;97:e12138.

Article  PubMed  Google Scholar 

Krinsley JS, Chase JG, Gunst J, Martensson J, Schultz MJ, Taccone FS, Wernerman J, Bohe J, De Block C, Desaive T, et al. Continuous glucose monitoring in the ICU: clinical considerations and consensus. Crit Care. 2017;21:197.

Article  PubMed  Google Scholar 

Schmidt S, Christensen MB, Serifovski N, Damm-Frydenberg C, Jensen JB, Floyel T, Storling J, Ranjan A, Norgaard K. Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study. Diabetes Obes Metab. 2019;21:1680–8.

Article  PubMed  Google Scholar 

Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, Yancy WS Jr, Brinkworth GD. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr. 2015;102:780–90.

Article  PubMed  Google Scholar 

Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97:505–16.

Article  PubMed  Google Scholar 

Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27:740–56.

Article  PubMed  Google Scholar 

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311–22.

Article  PubMed  Google Scholar 

Bajaj HS, Venn K, Ye C, Patrick A, Kalra S, Khandwala H, Aslam N, Twum-Barima D, Aronson R. Lowest glucose variability and hypoglycemia are observed with the combination of a glp-1 receptor agonist and basal insulin (VARIATION study). Diabetes Care. 2017;40:194–200.

Article  PubMed  Google Scholar 

Meneghini LF. Insulin therapy for type 2 diabetes. Endocrine. 2013;43:529–34.

Article  PubMed  Google Scholar 

Schmelzeisen-Redeker G, Schoemaker M, Kirchsteiger H, Freckmann G, Heinemann L, Del Re L. Time delay of CGM sensors: relevance, causes, and countermeasures. J Diabetes Sci Technol. 2015;9:1006–15.

Article  PubMed  Google Scholar 

Ajjan R, Slattery D, Wright E. Continuous glucose monitoring: a brief review for primary care practitioners. Adv Ther. 2019;36:579–96.

Article  PubMed  Google Scholar 

Wright LA, Hirsch IB. Metrics beyond hemoglobin A1C in diabetes management: time in range, hypoglycemia, and other parameters. Diabetes Technol Ther. 2017;19:S16–26.

Article  PubMed  Google Scholar 

Ugi S, Maegawa H, Morino K, Nishio Y, Sato T, Okada S, Kikkawa Y, Watanabe T, Nakajima H, Kashiwagi A. Evaluation of a novel glucose area under the curve (AUC) monitoring system: comparison with the AUC by continuous glucose monitoring. Diabetes Metab J. 2016;40:326–33.

Article  PubMed  Google Scholar 

Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther. 2011;13:921–8.

Article  PubMed  Google Scholar 

Brown E, Cuthbertson DJ, Wilding JP. Newer GLP-1 receptor agonists and obesity-diabetes. Peptides. 2018;100:61–7.

Article  PubMed  Google Scholar 

Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA. 2014;311:2315–25.

Article  PubMed  Google Scholar 

Abdalla MM. Central and peripheral control of food intake. Endocr Regul. 2017;51:52–70.

Article  PubMed  Google Scholar 

Pontiroli AE, Miele L, Morabito A. Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes Obes Metab. 2011;13:1008–19.

Article  PubMed  Google Scholar 

Brown A, Guess N, Dornhorst A, Taheri S, Frost G. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: what can be done? Diabetes Obes Metab. 2017;19:1655–68.

Article  PubMed  Google Scholar 

Salkind SJ, Huizenga R, Fonda SJ, Walker MS, Vigersky RA. Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature. J Diabetes Sci Technol. 2014;8:1042–7.

Article  PubMed  Google Scholar 

Ladenheim EE. Liraglutide and obesity: a review of the data so far. Drug Des Devel Ther. 2015;9:1867–75.

Article  PubMed  Google Scholar 

Mehta A, Marso SP, Neeland IJ. Liraglutide for weight management: a critical review of the evidence. Obes Sci Pract. 2017;3:3–14.

Article  PubMed  Google Scholar 

Gin H, Rigalleau V, Perlemoine C. Insulin therapy and body weight, body composition and muscular strength in patients with type 2 diabetes mellitus. J Nutr Metab. 2010. https://doi.org/10.1155/2010/340570.

Article  PubMed  Google Scholar 

Carris NW, Taylor JR, Gums JG. Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations. Drugs. 2014;74:2141–52.

Article  PubMed  Google Scholar 

Thomsen MN, Skytte MJ, Astrup A, Deacon CF, Holst JJ, Madsbad S, Krarup T, Haugaard SB, Samkani A. The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: a randomised controlled study. Clin Nutr ESPEN. 2020;39:46–52.

Article  PubMed  Google Scholar 

Alish CJ, Garvey WT, Maki KC, Sacks GS, Hustead DS, Hegazi RA, Mustad VA. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010;12:419–25.

Article  PubMed  Google Scholar 

Mori Y, Ohta T, Yokoyama J, Utsunomiya K. Effects of low-carbohydrate/high-monounsaturated fatty acid liquid diets on diurnal glucose variability and insulin dose in type 2 diabetes patients on tube feeding who require insulin therapy. Diabetes Technol Ther. 2013;15:762–7.

Article  PubMed  Google Scholar 

Sofizadeh S, Imberg H, Olafsdottir AF, Ekelund M, Dahlqvist S, Hirsch I, Filipsson K, Ahren B, Sjoberg S, Tuomilehto J, Lind M. Effect of liraglutide on times in glycaemic ranges as assessed by CGM for type 2 diabetes patients treated with multiple daily insulin injections. Diabetes Ther. 2019;10:2115–30.

Article  PubMed  Google Scholar 

Wang H, Zhou Y, Wang Y, Cai T, Hu Y, Jing T, Ding B, Su X, Li H, Ma J. Basal insulin reduces glucose variability and hypoglycaemia compared to premixed insulin in type 2 diabetes patients: a study based on continuous glucose monitoring systems. Front Endocrinol. 2022;13:791439.

Article  Google Scholar 

Tong CV, Mohd Noor N, Mohamad M. Glycemic Variability among Older Adults with Type 2 Diabetes. J Diabetes Metab. 2016. https://doi.org/10.4172/2155-6156.1000652.

Article  Google Scholar 

Gude F, Diaz-Vidal P, Rua-Perez C, Alonso-Sampedro M, Fernandez-Merino C, Rey-Garcia J, Cadarso-Suarez C, Pazos-Couselo M, Garcia-Lopez JM, Gonzalez-Quintela A. Glycemic variability and its association with demographics and lifestyles in a general adult population. J Diabetes Sci Technol. 2017;11:780–90.

Article  PubMed  Google Scholar 

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM. Sources of glucose variability in insulin-treated type 2 diabetes: the diabetes outcomes in veterans study (DOVES). Clin Endocrinol (Oxf). 2004;60:451–6.

Article  PubMed  Google Scholar 

Noyes JD, Soto-Pedre E, Donnelly LA, Pearson ER. Characteristics of people with high visit-to-visit glycaemic variability in type 2 diabetes. Diabet Med. 2018;35:262–9.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif